On December 22, Abogen announced that the Omicron variant BA.4/5 mRNA vaccine from its COVID-19 vaccine pipeline has recently initiated Phase III clinical trial participant enrollment in the Philippines and the UAE.
Abogen Biosciences Launches Phase III Clinical Trial Enrollment for Omicron BA.4/5 mRNA Vaccine in the Philippines and UAE
Dec 22, 2022 14:53
CST Updated
14:53
Abogen
Nucleic Acid Drug Developer